Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Valganciclovir Dosing in Pediatric Solid Organ Transplant Recipients - a Prospective Study

NCT02503982 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT02503982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02503982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Valganciclovir Dosing in Pediatric Solid Organ Transplant Recipients - a Prospective Study
Lead sponsor
Rabin Medical Center
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2014
Completion date
August 31, 2015
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infection in solid organ transplant recipients